Avecho Biotechnology Ord Shs V.AVE

Primary Symbol: AVEFF

Healthcare

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

OTCPK:AVEFF - Post by User

Avecho Biotechnology Ord Shs

Bullboard Posts

Comment by zadmanon Aug 22, 2017 4:48pm

163 Views

Post# 26609628

RE:RE:RE:RE:How low can she go?

You raise an interesting proposition Riskreward123. Aveda generates $20MM of EBITDA and provides an acquirer instant access to all the premier basins in the USD with an established Rolodex of customers. At the current stock level, an offer at a 100% premium (assuming Aveda debt on top) would cost only $40MM. Seems like a genius move for someone like Mullen Transport or another peer who may also be able to suck out additional synergies. Yah investors hate oil services but its truly amazing where they have pushed some of the valuations. If we were POT company, the market would think we are worth more than a billion..... zad

Bullboard Posts

FE Battery Metals begins 2024 winter drill program